Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06434753Phase 3Recruiting

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Role: collaborator

NCT06262256Not ApplicableCompleted

Effects of High-intensity Interval Training on Myocardial Strain in Metabolic Syndrome Patients

Role: collaborator

NCT05619250Not ApplicableUnknown

Supervised Center-based vs. Unsupervised Home-based Exercise Programs (PRO-Training)

Role: collaborator

NCT04707014Not ApplicableCompleted

Hypnoanalgesia for Dermatological Surgery in Children

Role: lead

All 4 trials loaded